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ABSTRACT
BACKGROUND: Group B streptococcus (GBS) is one of the principal agents of early onset neonatal sepsis, pneumonia and 
meningitis with significant morbidity for newborns and parturients. 
AIM: This study was done to determine the prevalence of vaginal group B streptococcus amongst parturients in FMC 
Owerri. It also aimed to elucidate the antibiotic sensitivity of the strains of GBS isolated while comparing the sensitivity of 
antigen detection tests of GBS to culture.
PATIENTS AND METHODS: This cross-sectional study was done at the labour ward and lying-in units of the Federal Medical 
Center, Owerri,from February 2015 to October, 2015. It involved one hundred and eighty (180) women recruited 
systematically. Two swab samples, high vaginal and rectal were collected from the parturients intrapartum and cultured. 
The babies were examined and weighed immediately after delivery, seen on the second and tenth days after delivery for 
features of fever or any other complaints.
RESULTS: The overall prevalence of GBS amongst parturients was found to be 6.1%. Prevalence of vaginal colonization was 
3.3% and that of the rectum was 2.8%, ( =0.1282, df=1,p=0.502). Neonates with colonized mothers all had complaints of 2c
fever postpartum which was statistically significant (=55.86, df=1, p<0.001). All the microbes showed 100% sensitivity to 
penicillin G, erythromycin, gentamycin and ceftriaxone. Antibiotic resistance was discovered in augmentin (67%), 
Cloxacillin (55.6%) and ofloxacin (33.3%). Antigen detection tests gave Sensitivity=100%, specificity=96.4%, positive 
predictive value (PPV) = 64.7%, negative predictive value (NPV) =100%. Detection in both vaginal (=60.290,p=0.000) and 
rectal (=50.799,p=0.000) samples were statistically significant.
CONCLUSION: The prevalence of GBS in parturients in the Centre is low. Strains of GBS isolated amongst the sampled 
rdpopulation in FMC Owerri had a high sensitivity to penicillin G, erythromycin, gentamycin and 3  generation 
cephalosporins. Antigen detection method for screening of GBS though very sensitive is however not specific with a 
significant false positive detection rate due to antigen cross reaction. It is however recommended that antigen detection 
be employed as intrapartum measure in high risk cases to reduce turnover time whilst supported by culture results later. 
There was associated significant neonatal sequaelae and further research to establish causal relationship will be advised. 
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roup B Streptococcus (Streptococcus 
Gagalactiae) is an important cause of neonatal and maternal infection. It is also 
a n  i m p o r t a n t  c a u s e  o f  d i s e a s e  i n 
1
immunocompromised adults and the elderly.  
Maternal GBS colonization rates in developing 
2
countries were estimated to be about 12.7%.  
Individual studies in Nigeria gave prevalence 
3,4,5
rates of 7.5% to 20%.   Prenatal cultures have 
been found not to accurately predict GBS carriage 
during labor. At least 4.0 to 11.6% of prenatally 
GBS-negative women had positive GBS cultures 
3during labor.  
Although the epidemiology of GBS in the 
developed world is well documented, its 
contribution to the burden of neonatal infection in 
the developing world has proved more difcult to 
5assess.  GBS incidence estimates from developing 
countries are confounded by case under-
ascertainment due to barriers to accessing 
healthcare and challenges in equipping and 
3,4,6
maintaining diagnostic laboratories.  Only 
Zimbabwe and Malawi have an active research 
programme on GBS colonization and burden of 
5,7disease.  
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Several factors increase the susceptibility of the 
parturients and their neonates to disease. These 
include; maternal age, occurrence of previous 
spontaneous abortion, presence of candidiasis and 
vaginitis, positive prenatal GBS culture, GBS 
bacteriuria during the current pregnancy, 
previous infant with invasive GBS disease, 
prolonged labour, low birth weight and black 
3,7,8race.  Others are; maternal fever in labour, 
gestational age more than 42 weeks, GBS strain 
3,7
(type III) and gestational diabetes.  Other less 
frequent modes of transmission include 
lactat ional ,  nosocomial  and community 
3,7,9
acquired.  
GBS is the most prevalent infection in the rst 
week of life, presenting in two forms: early-onset 
and late-onset. The newborns present with 
symptoms such as breathing problems, blood 
pressure and heart rate instability, gastro-
intestinal and urinary system disturbances, sepsis, 
pneumonia, meningitis, cellulitis, osteomyelitis, 
and septic arthritis. A late-onset infection usually 
presents with meningitis and septicemia in weeks 
8,9
or months after birth.
Intra-partum Antibiotic Prophylaxis (IAP) is 
usually offered to women who had the afore 
mentioned risk factors. Beta-lactam prophylaxis 
given 4 or more hours before delivery is highly 
10
effective and prevented 95% of EOD.  Studies in 
Africa and Nigeria have demonstrated good 
5,7,9,11sensitivity to penicillins.  The threat of 
antibiotic resistance has however emerged 
3,9worldwide.  
This has potential for public health concern 
especially in Nigeria, underlining the need for 
regional antibiotic surveillance and targeted 
treatment. Antigen testing and immunological 
tests have also been developed for GBS detection 
during labor in an effort to reduce turnover time 
and optimize specic intra-partum antibiotic 
9,12prophylaxis and avoid antibiotic resistance.  This 
may allow the screening of pregnant women from 
remote areas where there are no laboratory 
9,12facilities.
PATIENTS AND METHODS
Study population and sampling
This cross-sectional study was carried out in the 
labor and lying-in wards of the Federal Medical 
Center, Owerri, between February and October 
2015. After ethical approval, 180 parturients of 
different ages and parities that fullled the 
criteria were recruited at the delivery unit. 
Inclusion criteria included parturients in latent 
phase of labour at 37 completed weeks of 
gestation and above who have given informed 
consent for the study. 
Exclusion criteria included parturients currently 
on antibiotics or those who had used it in the last 
two weeks, signs of erosion on the cervix or 
vagina, those using feminine hygiene products 
and those who did not give consent.  A 
questionnaire was administered by the 
researchers to get the biodata and past obstetric 
history and other relevant information. Two swab 
samples were taken per participant by the 
researcher, using a sterile speculum from the 
vagina and another swab from the rectum under 
aseptic conditions.
Isolation and identication of organism
A commercially available collection and transport 
system for aerobes and anaerobes (Charcoal 
Swabs Amies Plastic Applicator with Rayon 
Tipped Black Cap, Stone, Staffs, UK) was 
employed. 
All swab specimen were transported to the 
Medical Microbiology Laboratory of The Federal 
Medical Center, Owerri. Modied Stuarts 
transport media was used in case of delay. The 
swab samples were inoculated into selective 
enrichment broth medium (Todd-Hewitt broth 
supplemented with 10G/ml colistin and 15G/ml 
nalidixic acid, Oxoid England) and incubated 
O
aerobically at 37 C for 24 hours. After 24 hours 
incubation, broth cultures were observed for 
growth (Turbidity). This was then sub-cultured 
onto 5% Sheep Blood Agar (Oxoid England) and 
incubated overnight as above. 
The colony appearance of GBS at 24 hours is 
usually grey, smooth, shiny, convex, moist, 
regular, soft and mucoid in appearance and about 
1 mm in diameter, often surrounded by a small 
hazy zone of beta- hemolysis. Suspected GBS 
isolates were identied based on colony 
morphology, catalase reaction, CAMP (Christy, 
Atkins, Munch, Peterson) test, hippurate 
hydrolysis test and Lanceeld grouping. 
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Antigen testing
GBS antigen was determined by serological 
grouping using Streptococcal group B reagent kit 
TM(Prolex ) testing of selective broth. Fresh (18-24) 
hour colony samples were used.  GBS colonies 
were picked from areas with the lowest 
probability of contamination with other 
organisms. A test tube was labeled for each isolate 
and a drop of extraction reagent 1 was added to 
each tube. 
A disposable needle was used to suspend the 
colonies in the test tubes till there is noticeable 
turbidity after which a drop of extraction reagent 2 
was added to each of the test tubes. Five drops of 
extraction reagent 3 were then added and each test 
tube was mixed by gentle tapping for 5-10 
seconds. A drop of the antigen reagent was 
dispensed on separate labeled test cards. 
A Pasteur pipette was used to dispense a drop of 
colony mixture beside each drop of reagent and 
both mixed with sticks provided. A new stick was 
used for each test circle. The cards were rocked 
gently allowing the mixture to ow slowly over 
the entire test ring area.  The mixture was 
observed for agglutination over one minute and 
recorded.
Antimicrobial susceptibility test
A small number of colonies obtained from each 24 
hours old 5% Sheep blood agar plate culture were 
incubated in Todd-Hewitt broth for 2 hours at 
O 5
37 C to obtain a McFarland level of turbidity of 10  
and logarithmic-growth phase culture. These 
were tested against different antibiotic discs 
which included penicillin G, ceftriaxone, 
cefotaxime, clindamycin, gentamycin and 
erythromycin using microdilution panels 
(MicroScan, Dade Behring Inc, USA). 
The isolates were considered susceptible or 
resistant according to the MIC (minimal 
i n h i b i t o r y  c o n c e n t r a t i o n )  b r e a k p o i n t s 
recommended by the Clinical and Laboratory 
13
Standards Institute (CLSI).  High-level resistance 
to gentamicin was dened as a MIC of ≥500 
µg/ml. Resistance to erythromycin was 
determined by the double-disk diffusion method 
with disks containing erythromycin (15 µg) and 
clindamycin (2 µg) onto sheep blood agar plates. 
Streptococcus pneumoniae ATCC 6305 was used as 
control organism and drug free plate was 
included as negative control.
RESULTS
One hundred and eighty (180) women were 
recruited and each had a vaginal/ rectal swab 
pair taken.
7
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Vaginal 6(3.3) 174(96.7) 180(100)
0.1282
df=1
0.502Rectal 5(2.8) 175(97.2) 180(100)




Table 1: Prevalence of Group B Streptococcus amongst parturients
FE= Fisher's Exact; P value
Prevalence of vaginal GBS 6(3.3%), was slightly higher than rectal GBS, 5(2.8%) amongst the 
participants. This difference however was not signicant ( =0.1282,df=1,p=0.502).None of the 2c
respondents had concomittant vaginal and rectal colonization.
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Table 2: Socio-demographic and obstetric characteristics of the mothers, birth weight and sex 
variations of neonates
All the pregnancies were term with an average gestational age of 39 weeks and 5 days + 11 days. Seventy 
three (40.6%) of the participants were within the 25-29 year age group with mean age of 28.2+4.2years. 
Most of the participants were booked, 175(97.2%), had a low parity of 0-1, 114(63.3%) were HIV negative, 
161(89.4%), and had tertiary education, 115 (63.9%). Most of the neonates weighed between 2.5-4.0kg 
(85.6%) with an average weight of 3.42+0.40kg. 6(3.4%) of them were of low birth weight. One hundred 
and four(57.8%) of the births were male, with a male to female ratio of 1.4:1. ( Table 2) 




























































































































































None of the neonates born to mothers with vaginal 
colonization was of low birth weight. All neonates 
of mothers with vaginal GBS colonization had 
nd th
complaints on the 2  and 10  day. This difference 
was statistically signicant (p=<0.05).
Figure 1: Prole of cultured micro-organisms in 
vaginal swabs
One hundred and thirty four (74.4%) microbial 
growth in vaginal swabs was recorded. 57 (31.7%) 
of the participants had mixed bacterial growth 
while 46(25.6%) had no growth. The values for S 
agalactiae and C albicans were 6.1% and 3.3% 
respectively while C albicans and Coliform bacilli 






















Figure 2: Antibiotic sensitivity/resistance 
prole of GBS isolates
Erythromycin,  penicil l in G, gentamycin, 
ceftriaxone and cefuroxime were found to have a 
high sensitivity in all cultured samples (100%). 
Clindamycin had 90% sensitivity. Sixty seven 
percent (66.7%) of the isolates were sensitive to 
Ooxacin while 33.3% were resistant. For 
Cloxacillin, 44.4% were sensitive while 55.6% were 
res is tant .  Augmentin  showed only  33% 
sensitivity. One (11.1%) strain exhibited a multiple 
antibiotic resistance pattern.  
 
 











Figure 3:Antibiotic sensitivity of the strains of 
GBS isolated from the affected respondents
Antimicrobial susceptibility pattern of the 11 GBS 
isolates is shown in Figure 3. The X-axis represents 
the Zone of Growth Inhibition of the antibiotic 
disc in millimeters. Zones of 6 and below are 










































Table 4: Antigen detection in culture positive 












Antigen negative 0 163 163
Total 11 169 180
Sensitivity=100%, specicity=96.4%, positive predictive 
value (PPV)=64.7%, negative predictive value (NPV)=100%
DISCUSSION
The prevalence of vaginal group B streptococcus 
(GBS) in this study was 3.3 % (table 1). When 
combined with values of 2.8% obtained from 
rectal samples this gives an overall GBS rate of 
6.1%. This value is comparable to values of 2.5% 
14
by Konikkara et al  but much lower than that 
found in local studies; 8.3% in Ibadan, 9.8% in 
9,7,3,4
Maiduguri,11.3% in Ile-Ife and 18% in Enugu.  
Studies in other localities also gave higher values 
11
of 7.5% in India , 12% in the Indo-Pakistan, 20% in 
2 5 6
Gambia , 16.5% in Malawi , 22.76% in Iran  and 
825.4% by Rochetti et al. 
The difference in values may be attributed to the 
fact that GBS maternal colonization varies from 
place to place. Local studies by Onipede et al and 
Okon et al used specimen from the introitus and 
3,7
lower vagina respectively. Also, the study by 
11Hajare et al was done with lower vaginal swabs.  
This may suggest a higher yield due to proximity 
9
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to the surface skin and anus. Racial and genetic 
factors are contributory factors as documented in 
some studies suggesting innate ability to clear 
11colonization.
The clients most affected in this study were in the 
25-29 year age group with a mean age of 28.2 + 
4.2years (table 2). This was comparable to ndings 
by Okon et al and Javanmanesh et al where the 
6,7mean ages were 28.7 years and 26.7 respectively.  
In other studies, the most affected ages ranged 
between 31-45 years, suggesting no particular 
4,8,11association with age.  Women with lower 
parities of 0-1 were more affected in this study 
although this was not statistically signicant. This 
was also observed in the study by Hajare et al 
where 46.7% isolat ion rate  was seen in 
primigravidae, while 25.5% prevalence was seen 
11,4in primiparae by Ezeonu et al.  Women with 
tertiary education only were affected in this study. 
This was a similar nding in the study done in 
7Maiduguri.  The reason for this is unclear. No 
denite pattern was found with parity and 
6,9educational level in several other studies.  None 
of the affected women was HIV positive. This is 
supported by Stoll et al that showed no overall 
difference in GBS carriage rate in HIV positive 
2
women . 
This differed from a nding in Malawi that gave a 
5prevalence of 44%.  This nding may probably 
reect the overall HIV positivity rate amongst 
their parturients. HIV positive women in this 
center are managed with Cotrimoxazole as 
prophylaxis all through their pregnancy and this 
may be protective. Streptococcus agalactiae 
occurred in all samples found positive for GBS. 
The ratio of vaginal to rectal colonization was 
found to be 1.2:1. This was comparable to ndings 
4by Ezeonu et al who found an equal ratio  but 
differed from Konnikara et al that suggested that 
14anal swabs gave a better yield.  None of the clients 
in this study showed concomitant infection of both 
the vagina and the rectum.
The sampling for GBS carriage among pregnant 
women is recommended to be done at the third 
trimester which provides the information 
necessary for antibiotic prophylaxis prior to 
10
delivery.  The United States policy is more 
aggressive with routine screening of all women 
and concordant reduction in early onset disease 
(EOD). European countries however are more 
conservative, with screening done for women 
with high risk factors combined with early 
10
treatment of neonatal disease.  This has been 
found to reduce the cost of screening while 
ensuring patients at risk are taken care of. It may 
also ensure earlier screening for women who are 
at high risk to avoid preterm deliveries. In this 
study however, none of the parturients found 
colonized with GBS had any known risk factors. 
This may have been due to their low gravidity, as 
most affected mothers were primigravidae and 
primiparae. Also, the possibility exists that 
women with established risk factors may have 
been delivered before term as preterm delivery is 
one of the complications of vaginal GBS 
colonization. 
One of the most important risk factors for EOD in 
the neonate is exposure to the organism 
colonizing the mother's genital tract. All the 
neonates whose mothers screened positive for 
vaginal GBS had post-partum complaints (table 3) 
ranging from fever, 6(3.3%) in the 1st 2 days to 
admission in the special care baby unit 3(1.7%) by 
the tenth day. This was a statistically signicant 
association (p<0.001). Vertical transmission rates 
have been shown to approach 70% with 2-3 fold 
higher incidence than blood / cerebro-spinal uid 
15,16proven sepsis.  No neonatal death was recorded 
in the time frame this study was done although 
the incidence of late onset GBS infections was not 
done.
In this study there was 74.4% microbial growth in 
vaginal swabs while 25.6% of samples showed no 
bacterial growth (gure 1). This was lower than 
ndings in Ibadan where the microbial isolation 
9
rate was 92%.  Higher numbers of S aureus and 
Candida species were also isolated (18.3% and 
14.2% respectively) against 11.1% and 3.3% each 
found in this study. Coliformlevels were however 
higher in this study with values of 22.2% against 
9
15% found in the study by Dombraye et al .
 The relatively higher recovery of coliforms from 
v a g i n a l  s w a b s  m a y  h a v e  b e e n  d u e  t o 
contamination from rectal contents during the 
birth process and obstetric procedures the 
parturients were subjected to. Although intra-
partum vaginal examinations are done as 
aseptically as possible in this Centre, this 
possibility cannot be ruled out. All the GBS 
species isolated were sensitive to penicillin G, 
10
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erythromycin,  gentamycin,  cef tr iaxone, 
cefuroxime (100%) and clindamycin (90%) (gures 
2,3). This was consistent with ndings by Hajare et 
al in 2012 and Dombraye et al in 2010 where 
erythromycin and penicillin were found to have 
11,9100% sensitivity . There was also 80% sensitivity 
11,9
to ampicillin, vancomycin and augmentin.  This 
corroborates the revised recommendation by the 
CDC (2010) that penicillin G be the rst line of 
treatment for women with GBS colonization in 
1 2labour.  The antibiot ics  vancomycin or 
clindamycin may be employed in those that have 
12serious penicillin G allergy.  Marked resistance to 
augmentin (67%) and cloxacillin (55.6%) was 
noted in this study, and differed from the ndings 
of resistance to gentamycin and kanamycin in the 
11Hajare study (100% and 80% respectively).  
Resistance to quinolones (peroxacin and 
ciprooxacin) has only recently been described for 
3
GBS  and also noted in this study with Ooxacin 
having a resistance of 33.3%. 
Resistance of GBS to erythromycin and penicillin 
G, though not seen in this study, has been reported 
by several other studies and also noted by Ezeonu 
4,3et al (8.6%) and Onipede et al (40%). As penicillin 
is the rst line treatment for intra-partum GBS this 
may be a cause for worry in Nigeria. The resistance 
noted with augmentin and cloxacillin in this study 
may be related to the ease of procurement of over 
the counter antibiotics in the country for self-
medication and its frequent use for therapy, 
3,7prophylaxis and other socio economic factors . 
This may have led to the emergence of multiple 
drug resistant strains of GBS to these common 
rd
antibiotics. The high sensitivity noted with the 3  
generation cephalosprins and gentamycin in this 
study may have been due to the relatively 
expensive nature of the drugs and the need for 
parenteral administration which makes them 
unattractive for over the counter purchase. As 
r e c o m m e n d e d  b y  t h e  C D C ,  a n t i b i o t i c 
susceptibility testing should be performed if 
therapy is needed to avoid neonatal GBS 
3,12
infection .If antibiotic resistance continues to be 
identied and found to be on the increase, 
surveillance of antibiotic resistance patterns 
among several antimicrobial classes will be 
important in determining optimal prophylaxis 
and treatment of GBS infections.  GBS colonization 
was conrmed by antigen detection from 
enrichment broth culture and direct culture 
isolation of the swab samples (Table 4).  
The antigen detection test in this study gave a 
sensitivity of 100% and a specicity of 96.4% 
comparable to values of 100% and 95.6% recorded 
3by Onipede et al . There was also a positive 
predictive value (PPV) of 64.7% and a negative 
predictive value (NPV) of 100%. This was much 
lower than the PPV of 80% seen in the study in Ile-
3
Ife.  Eleven (11) out of the 17 pregnant women that 
were positive forantigen detection by latex 
agglutination test after 18 hours incubation in 
enrichment broth were also culture positive.  In 
the 6 cases where there was antigen positivity and 
negative culture, possible explanation could 
include cross reaction with other microbial 
antigens as no GBS was cultured even after 72 
hours. 
In all those cases coliforms was noted as heavy 
growth and this may have affected the outcome. 
Though antigen detection kits reliably reduced 
the waiting time from 24-48hours to 18hours 
thereby allowing evidence based antibiotic 
therapy earlier on in labour, this nding suggests 
that culture is still the gold standard for isolation. 
Antigen detection kits may be used for screening 
and eld studies due to its higher sensitivity, 
16lower cost and easy assay.  This can isolate 
women who may then be followed up by culture 
to avoid development of antibiotic resistance.
CONCLUSION
The prevalence of GBS in parturients in the Centre 
is low. Strains of GBS isolated amongst the 
sampled population in FMC Owerri had a high 
sensitivity to penicillin G, erythromycin, 
rd
gentamycin and 3  generation cephalosporins. 
Antigen detection method for screening of GBS 
though very sensitive is however not specic with 
a signicant false positive detection rate due to 
a n t i g e n  c r o s s  r e a c t i o n .  I t  i s  h o w e v e r 
recommended that antigen detection be 
employed as intrapartum measure in high risk 
cases to reduce turnover time whilst supported by 
culture results later. There was associated 
signicant neonatal sequaelae and further 
research to establish causal relationship will be 
advised. 
CONSENT
All authors declare that written informed consent 
was obtained from the patient for publication of 
this paper.
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